MedPath
HSA Approval

FLUCOL CAPSULE

SIN08881P

FLUCOL CAPSULE

FLUCOL CAPSULE

August 28, 1996

ORIGOPHARM PTE LTD

ORIGOPHARM PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantORIGOPHARM PTE LTD
Licence HolderORIGOPHARM PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N02BE51

paracetamol, combinations excl. psycholeptics

Manufacturer Information

ORIGOPHARM PTE. LTD.

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

PHENYLEPHRINE HCl

2.5 mg

Phenylephrine

PARACETAMOL

250 mg

Acetaminophen

CAFFEINE (ANHYDROUS)

15 mg

Caffeine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FLUCOL CAPSULE - HSA Approval | MedPath